Nirmidas Biotech Stock
Nirmidas provides innovative solutions
Sign up today and learn more about Nirmidas Biotech Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nirmidas Biotech Stock
Nirmidas provides innovative solutions to life science and healthcare technological problems and aims to improve human life quality for the world. Nirmidas develops, manufactures, and markets breakthrough biological testing, assay and imaging technologies, based on a novel red to near infrared fluorescence enhancing detection platform. We aim to develop personal and portable diagnostics systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening. Our products lie at the intersection of life science research, in vitro diagnosis and digital healthcare.
Funding History
August 2014 | $2.0M |
---|---|
February 2016 | $5.0M |
Management
Co-founder - CEO
Meijie Tang
Co-Founder
Hongjie Dai
Press
massdevice - Jan, 9 2021
FDA authorizes fingerstick COVID-19 antibody testbioworld - Jan, 6 2021
Regulatory actions for Jan. 5, 2021